• Madrigal Pharmaceuticals average return on equity for 2024 was -88.48, a 67.37% decline from 2023.
• Madrigal Pharmaceuticals average return on equity for 2023 was -271.19, a 36.52% decline from 2022.
• Madrigal Pharmaceuticals average return on equity for 2022 was -198.64, a 120.88% increase from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.